中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 2
Mar.  2021
Turn off MathJax
Article Contents

Indications for liver transplantation in children with hepatic malignancies

DOI: 10.3969/j.issn.1001-5256.2021.02.004
  • Received Date: 2020-10-22
  • Accepted Date: 2020-11-16
  • Published Date: 2021-02-20
  • There are significant differences in origin and development between pediatric liver malignancies and adult liver malignancies, and even for the same type of liver cancer, there are still differences in its development, progression, therapies, and treatment outcome between children and adults. The histological manifestation and anatomical location of pediatric liver malignancies can reflect the characteristics of invasion and metastasis, the difficulty in surgical treatment, and the sensitivity of drug therapy. Therefore, treatment modalities should be selected based on these characteristics. Pediatric liver malignancies are more sensitive to adjuvant therapy such as chemotherapy, and the combination with adjuvant therapies, such as chemotherapy, before or after liver transplantation may achieve satisfactory results and thus expand the indications for liver transplantation. Among pediatric liver malignancies, hepatoblastoma, hepatocellular carcinoma, and undifferentiated embryonal sarcoma is more common and can be treated by liver transplantation with satisfactory prognosis. Liver transplantation should be considered for children with malignant liver tumors confined to the liver and poor response to liver resection.

     

  • loading
  • [1]
    LITTEN JB, TOMLINSON GE. Liver tumors in children[J]. Oncologist, 2008, 13(7): 812-820. DOI: 10.1634/theoncologist.2008-0011
    [2]
    NG K, MOGUL DB. Pediatric liver tumors[J]. Clin Liver Dis, 2018, 22(4): 753-772. DOI: 10.1016/j.cld.2018.06.008
    [3]
    SINDHI R, ROHAN V, BUKOWINSKI A, et al. Liver transplantation for pediatric liver cancer[J]. Cancers (Basel), 2020, 12(3): 720. DOI: 10.3390/cancers12030720
    [4]
    SUNIL BJ, PALANIAPPAN R, VENKITARAMAN B, et al. Surgical resection for hepatoblastoma-updated survival outcomes[J]. J Gastrointest Cancer, 2018, 49(4): 493-496. DOI: 10.1007/s12029-017-0005-z
    [5]
    SHARMA D, SUBBARAO G, SAXENA R. Hepatoblastoma[J]. Semin Diagn Pathol, 2017, 34(2): 192-200. DOI: 10.1053/j.semdp.2016.12.015
    [6]
    WANG LL, FILIPPI RZ, ZURAKOWSKI D, et al. Effects of neoadjuvant chemotherapy on hepatoblastoma: A morphologic and immunohistochemical study[J]. Am J Surg Pathol, 2010, 34(3): 287-299. DOI: 10.1097/PAS.0b013e3181ce5f1e
    [7]
    ZSIROS J, BRUGIERES L, BROCK P, et al. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): A prospective, single-arm, feasibility study[J]. Lancet Oncol, 2013, 14(9): 834-842. DOI: 10.1016/S1470-2045(13)70272-9
    [8]
    TRIANA JUNCO P, CANO EM, DORE M, et al. Prognostic factors for liver transplantation in unresectable hepatoblastoma[J]. Eur J Pediatr Surg, 2019, 29(1): 28-32. DOI: 10.1055/s-0038-1668148
    [9]
    FUCHS J, CAVDAR S, BLUMENSTOCK G, et al. POST-TEXT Ⅲ and Ⅳ hepatoblastoma: Extended hepatic resection avoids liver transplantation in selected cases[J]. Ann Surg, 2017, 266(2): 318-323. DOI: 10.1097/SLA.0000000000001936
    [10]
    RAMMOHAN A, RELA M, KUMAR GV, et al. Outcomes for high-risk hepatoblastoma in a resource-challenged setting[J]. BJS Open, 2020, 4(4): 630-636. DOI: 10.1002/bjs5.50297
    [11]
    TROBAUGH-LOTRARIO AD, MEYERS RL, TIAO GM, et al. Pediatric liver transplantation for hepatoblastoma[J]. Transl Gastroenterol Hepatol, 2016, 1: 44. DOI: 10.21037/tgh.2016.04.01
    [12]
    OTTE JB, PRITCHARD J, ARONSON DC, et al. Liver transplantation for hepatoblastoma: Results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience[J]. Pediatr Blood Cancer, 2004, 42(1): 74-83. DOI: 10.1002/pbc.10376
    [13]
    MARIN J, CIVES-LOSADA C, ASENSIO M, et al. Mechanisms of anticancer drug resistance in hepatoblastoma[J]. Cancers (Basel), 2019, 11(3): 407. DOI: 10.3390/cancers11030407
    [14]
    KHANNA R, VERMA SK. Pediatric hepatocellular carcinoma[J]. World J Gastroenterol, 2018, 24(35): 3980-3999. DOI: 10.3748/wjg.v24.i35.3980
    [15]
    LEE CL, KO YC. Survival and distribution pattern of childhood liver cancer in Taiwan[J]. Eur J Cancer, 1998, 34(13): 2064-2067. DOI: 10.1016/S0959-8049(98)00281-0
    [16]
    MOORE SW, MILLAR AJ, HADLEY GP, et al. Hepatocellular carcinoma and liver tumors in South African children: A case for increased prevalence[J]. Cancer, 2004, 101(3): 642-649. DOI: 10.1002/cncr.20398
    [17]
    CHANG MH, CHEN CJ, LAI MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group[J]. N Engl J Med, 1997, 336(26): 1855-1859. DOI: 10.1056/NEJM199706263362602
    [18]
    CHANG MH, YOU SL, CHEN CJ, et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: A 20-year follow-up study[J]. J Natl Cancer Inst, 2009, 101(19): 1348-1355. DOI: 10.1093/jnci/djp288
    [19]
    MURAWSKI M, WEEDA VB, MAIBACH R, et al. Hepatocellular carcinoma in children: Does modified platinum- and doxorubicin-based chemotherapy increase tumor resectability and change outcome? Lessons learned from the SIOPEL 2 and 3 studies[J]. J Clin Oncol, 2016, 34(10): 1050-1056. DOI: 10.1200/JCO.2014.60.2250
    [20]
    CZAUDERNA P, MACKINLAY G, PERILONGO G, et al. Hepatocellular carcinoma in children: Results of the first prospective study of the International Society of Pediatric Oncology group[J]. J Clin Oncol, 2002, 20(12): 2798-2804. DOI: 10.1200/JCO.2002.06.102
    [21]
    SHI Y, ROJAS Y, ZHANG W, et al. Characteristics and outcomes in children with undifferentiated embryonal sarcoma of the liver: A report from the National Cancer Database[J]. Pediatr Blood Cancer, 2017, 64(4): e26272. DOI: 10.1002/pbc.26272
    [22]
    PLANT AS, BUSUTTIL RW, RANA A, et al. A single-institution retrospective cases series of childhood undifferentiated embryonal liver sarcoma (UELS): Success of combined therapy and the use of orthotopic liver transplant[J]. J Pediatr Hematol Oncol, 2013, 35(6): 451-455. DOI: 10.1097/MPH.0b013e318271c948
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (466) PDF downloads(36) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return